Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Abdi, Salahadin

University Of Tx Md Anderson Can Ctr
United States

Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study 5R21CA256136-02 PAR-20-292 (R21 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.
Abrams, Julian

Columbia University Health Sciences
United States

The Oral Microbiome for the Detection of Barretts Esophagus 5R01CA238433-04 Matthew Young, Ph.D.
Abyzov, Alexej

Mayo Clinic Rochester
United States

Detection of somatic, subclonal and mosaic CNVs from sequencing 5U24CA220242-05 Christos Patriotis, Ph.D., M.Sc.
Acciavatti, Raymond Joseph

University Of Pennsylvania
United States

Next-Generation Tomosynthesis Pilot Study 1R37CA273959-01 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Richard Mazurchuk, Ph.D.
Acharya, Munjal M

University Of California-Irvine
United States

Stem cell-derived exosomes to ameliorate chemobrain 1R01CA262213-01A1
Adams-Campbell, Lucile Lauren

Georgetown University
United States

National Capital Area (NCA) Minority/Underserved NCORP 5UG1CA239758-04 Worta McCaskill-Stevens, M.D., M.S.
Agarwal, Rajesh

University Of Colorado Denver
United States

Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy 3R01CA140368-10S1 PA-20-227 (Admin Supp-Clinical Trial Not Allowed) Amit Kumar, Ph.D.
Agarwal, Ashutosh

University Of Miami School Of Medicine
United States

A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer 5U01CA233363-05 Lynn Sorbara, Ph.D.
Agsalda-Garcia, Melissa Anne

University Of Hawaii At Manoa
United States

Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients 1R21CA244078-01 PAR-18-020 (R21 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Ah, Diane Marie Von

Ohio State University
United States

Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial 1R01CA276222-01 PAR-21-035 (R01 Clinical Trial Required)